#ESHREjc report: Is OTO-IVM the future fertility preservation alternative for urgent cancer patients?
(2021) Human reproduction — Vol. 36, n° 9, p. 2631-2633 (2021)
Files
Massarottietal-HumReprod2021.pdf
Open Access - Adobe PDF
- 388.4 KB
Details
- Authors
Fraire-Zamora, Juan J 
- Abstract
- (en) Fertility preservation for cancer patients (oncofertility) is still a relatively new discipline, given the increase in survival rates of patients undergoing chemotherapy. Ovarian stimulation followed by cryopreservation are the routine techniques recommended for post-pubertal cancer patients (The ESHRE Guideline Group on Female Fertility Preservation et al., 2020). However, there are many patients who have a contraindication for ovarian stimulation, need an urgent anticancer treatment or are pre-pubertal. Despite the impressive progress in fertility preservation in recent decades, we still lack options with proven safety and efficacy for many of these patients. [...]
- Affiliations
Citations
Massarotti, C., Kohlhepp, F., Liperis, G., Ammar, O. F., Mincheva, M. N., Ali, Z. E., Andrade Amorim, C., Anderson, R., & Fraire-Zamora, J. J. (2021). #ESHREjc report: Is OTO-IVM the future fertility preservation alternative for urgent cancer patients? Human reproduction, 36(9), 2631-2633. https://doi.org/10.1093/humrep/deab180 (Original work published 2021)